by Tony Akiwumi | Nov 20, 2025 | Pharma / Market Access
Every organisation has them. The people who see patterns nobody else sees. The ones who ask questions that make the room uncomfortable. The colleagues who want to move faster, think differently, and make things better. They are called innovators, challengers, or...
by Tony Akiwumi | Nov 20, 2025 | Pharma / Market Access
Every organisation says it wants innovation. Yet many of the people most capable of creating it eventually walk out of the door. They are the ones who question assumptions, challenge hierarchy, and move faster than the system allows. Within the organisation, they are...
by Tony Akiwumi | Nov 20, 2025 | Pharma / Market Access
Some of the most successful people I know once struggled to fit into corporate life. I have seen it firsthand. One became a billionaire four times over. Another built and sold his business for three hundred million pounds. A few others have created companies now...
by Tony Akiwumi | Nov 19, 2025 | Pharma / Market Access
In 2017, a major global bank spent nearly £300 million developing a digital platform that it eventually scrapped. The reason? No one had the courage to stop it earlier. Everyone feared appearing negative. Leadership meetings became exercises in optimism rather than...
by Tony Akiwumi | Nov 19, 2025 | Pharma / Market Access
When athletes train for the Olympics, they receive constant feedback — not once a year, but every session. Yet in corporate life, feedback often arrives too late to make a difference. Performance reviews become rituals rather than instruments of growth. Feedback is...
by Tony Akiwumi | Nov 19, 2025 | Pharma / Market Access
When the Concorde first took flight, it symbolised bold innovation. It was beautiful, fast, and technologically unmatched. Yet, it failed commercially because the strategic balance between creativity and risk was never resolved. It was an engineering triumph but a...
